MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2019 International Congress

    A case of hemimasticatory spasm with well therapeutic response to serial injections of botulinum toxin

    SK. Yang, JJ. Lin (Changhua County, Taiwan)

    Objective: To report a case with hemimasticatory spasm responsive to serial botulinum toxin injections. Background: Hemimasticatory spasm is a rare neurologic disorder characterized by involuntary…
  • 2019 International Congress

    Development of a patient-reported Botulinum Toxin Response Scale (BTRS) for neurological disorders: a feasibility study.

    D. Gupta, C. Gao, S. Pullman (Burlington, VT, USA)

    Objective: To assess the feasibility of developing a patient-reported Botulinum Toxin Response Scale (BTRS) for different neurological conditions. Background: Botulinum toxin (BoNT) is a highly…
  • 2019 International Congress

    Onset of action for rimabotulinumtoxinB in the treatment of adult sialorrhea

    L. Bahroo, S. Isaacson, R. Pahwa, D. Chary, T. Clinch, M. Lew (Washington, DC, USA)

    Objective: To assess the onset of action for rimabotulinumtoxinBinjections in the salivary glands for the treatment of sialorrhea. Background: Sialorrhea (drooling) causes significant morbidity including impaired oral…
  • 2019 International Congress

    The effects of onabotulinum toxin on neurophysiological tests in patients with hemifacial spasm

    O. Kocak, A. Tokcaer (Ankara, Turkey)

    Objective: We aimed to investigate effects of onabotulinum toxin (OnaBoNT) on clinical and neurophysiological findings of patients with hemifacial spasm (HFS). Background: There is a…
  • 2019 International Congress

    Long-term safety and efficacy of rimabotulinumtoxinB in the treatment of adult sialorrhea

    K. Dashtipour, S. Isaacson, M. Lew, D. Chary, T. Clinch, R. Pahwa (Boca Raton, FL, USA)

    Objective: To assess the safety, tolerability and effectiveness of repeated rimabotulinumtoxinB injections in adults with troublesome sialorrhea over a period of 1 year. Background: Sialorrhea…
  • 2019 International Congress

    Describing Dystonia Phenomenology and Preliminary Treatment Response in Migraine Patients

    A. Yoo, S. Bobker, S. Broner, A. Lee, G. Auerbach, L. Klebanoff, M. Vo, H. Sarva (New York, NY, USA)

    Objective: To describe dystonia phenomenology and preliminary pain response to toxin therapy in a single-center migraine cohort. Background: The co-existence of headache and craniocervical dystonia…
  • 2019 International Congress

    RimbotulinumtoxinB in the treatment of adult sialorrhea

    S. Isaacson, W. Ondo, M. Lew, K. Dashtipour, D. Chary, T. Clinch, F. Pagan (Boca Raton, FL, USA)

    Objective: To assess efficacy, safety and tolerability of repeat injections of rimabotulinumtoxinBfor the treatment of sialorrhea. Background: Sialorrhea (drooling) can cause significant morbidity in several neurological disorders,…
  • 2019 International Congress

    Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs in spastic hemiparesis: baseline data from the ENGAGE study

    J-M. Gracies, G. Francisco, R. Jech, S. Khatkova, C. Rios, P. Maisonobe (Créteil, France)

    Objective: To report baseline data from ENGAGE, an international phase 3b/4, prospective, single-arm, open-label study (NCT02969356) conducted in France, the Czech Republic, Russia and the USA.…
  • 2019 International Congress

    Duration of rimabotulinumtoxinB action in the treatment of adult sialorrhea

    S. Isaacson, M. Lew, F. Pagan, R. Pahwa, D. Chary, T. Clinch (Boca Raton, FL, USA)

    Objective: To assess the duration of rimabotulinumtoxinB action in the management of sialorrhea. Background: In neurological disorders, sialorrhea (drooling) is both prevalent and problematic. Local…
  • 2019 International Congress

    The effect of Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs on voluntary movements in adults with spastic hemiparesis

    J-M. Gracies, G. Francisco, R. Jech, S. Khatkova, C. Rios, P. Maisonobe (Créteil, France)

    Objective: To report primary outcomes from ENGAGE, an international phase 3b/4, prospective, single-arm, open-label study (NCT02969356). Background: ENGAGE assessed effects of Guided Self-rehabilitation Contracts (GSC)…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 12
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley